NexgenRx Announces Share Issuances Under Consulting Agreement

NexgenRx Inc. has announced the issuance of 195,312 common shares at $0.32 per share. This issuance is part of the company's consulting agreement with PBM Management Services. The share issuance corresponds to the fourth quarterly equity payment under the agreement. All required services for this payment have been completed.

The consulting services will be recorded in NexgenRx's financial statements for the period ending June 30, 2024. The shares are subject to a four-month hold period under applicable securities laws, expiring on November 19, 2024.

NexgenRx is a Canadian Third-Party Administrator and Technology Solutions Provider. The company offers various administrative and health benefit technology services through a SaaS model. Partners can expect competitive, superior administration and claims processing solutions.